Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Seth Ettenberg in Biotechnology
Introduction
Seth Ettenberg, an accomplished inventor based in Cambridge, MA, has made significant strides in the field of biotechnology. His work focuses on genetic engineering, particularly in the development of therapies aimed at targeting specific antigens in various medical applications.
Latest Patents
Ettenberg holds a patent titled "Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating Krebs cycle and therapeutic uses thereof." This innovative patent discloses genetically engineered hematopoietic cells that express various Krebs cycle-modulating polypeptides and optionally a chimeric receptor polypeptide, such as an antibody-coupled T cell receptor or a chimeric antigen receptor. These engineered cells have significant therapeutic potential for inhibiting cells that express a target antigen in patients who require such treatment.
Career Highlights
Ettenberg's career is marked by his dedication to research and development in the biotechnology sector. Currently, he is part of Sotio Biotech Inc., a company renowned for its commitment to advancing cancer immunotherapy and cell therapy technologies. His work at the company reflects a strong synergy between scientific innovation and practical applications aimed at improving patient outcomes.
Collaborations
Throughout his career, Ettenberg has collaborated with talented individuals such as Kathleen McGinness and Luke Barron. Working alongside these colleagues, he has contributed to the advancement of cutting-edge technologies within the realm of hematopoietic cell engineering and cancer therapeutics, fostering an environment of innovation and discovery.
Conclusion
Seth Ettenberg stands out as a significant figure in biotechnology with his inventive contributions that hold promise for the future of therapeutic interventions. His patent on chimeric antigen receptor polypeptides showcases his expertise in genetic engineering and the potential to transform treatment modalities for patients in need. As he continues to work with leading experts, the impact of his innovations is likely to grow, paving the way for breakthroughs in medical science.